2 March 2019

 

Consilium Strategic Communications advises Cambridge Innovation Capital on £150 million new capital raise

 

London, 2 April 2019, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is proud to have supported Cambridge Innovation Capital plc (CIC), the venture capital investor focused on IP-rich technology and life science businesses in the Cambridge ecosystem, on its £150 million fundraise.

 

The financing was supported by a geographically diverse range of new institutional and strategic investors, with the University of Cambridge and Cambridge University Endowment Fund contributing the cornerstone investment which brings the total amount of capital raised by CIC to date to £275 million. The financing is one of the largest private financing rounds in Europe this year and more than doubles the financial resources available to CIC.  The funds will be used to support CIC’s current portfolio of 25 companies and enable investment in new opportunities arising from both the University of Cambridge and the wider Cambridge ecosystem.

“CIC has gone from strength to strength since its inception in 2013 and is now the key healthcare and tech investor within the Cambridge ecosystem. Consilium is proud to work closely with CIC and was pleased to advise on this successful fundraise, one of the largest private rounds in Europe this year. We look forward to continuing to work with the CIC team as it deploys this capital and continues to grow.”

Mary-Jane Elliott

Managing Partner of Consilium Strategic Communications

To view CIC’s announcement please visit https://www.cicplc.co.uk/

 

-Ends-

 

For more information, please contact:

 

Consilium Strategic Communications

Mary-Jane Elliott / Amber Fennell

Tel: +44(0)20 3709 5700

info@consilium-comms.com

www.consilium-comms.com

Follow us: @consiliumhc

 

About Consilium Strategic Communications

 

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly-skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects.

 

 

About Cambridge Innovation Capital plc

 

Cambridge Innovation Capital (CIC) is a venture capital investor focused on intellectual property

rich technology and life science businesses in the Cambridge ecosystem. CIC is committed to

building leading businesses from brilliant technologies. It combines a unique relationship with the

University of Cambridge with deep financial and industry links to support these businesses as they

seek to fulfil their potential to change the world of tomorrow.

 

For more information please visit www.cicplc.co.uk or follow on Twitter at @CambsInnovation


Back to previous page